Biosion Tech Stack

Media & News

Biosion's Email Address Formats

Biosion uses at least 2 format(s):
Biosion Email FormatsExamplePercentage
first.last@biosion.comJohn.Doe@biosion.com
50%
first.last@biosion.comJohn.Doe@biosion.com
50%

Frequently Asked Questions

Where is Biosion's headquarters located?

Minus sign iconPlus sign icon
Biosion's main headquarters is located at Building D, 3-1 Zhongdan Unit, South Longshan Rd, Jiangbei New District 5th Floor Nanjing, Jiangsu 210061 CN. The company has employees across 2 continents, including AsiaNorth America.

What is Biosion's official website and social media links?

Minus sign iconPlus sign icon
Biosion's official website is biosion.com and has social profiles on LinkedIn.

What is Biosion's SIC code NAICS code?

Minus sign iconPlus sign icon
Biosion's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Biosion have currently?

Minus sign iconPlus sign icon
As of February 2024, Biosion has approximately 22 employees across 2 continents, including AsiaNorth America. Key team members include Chief Operating Officer & President, Biosion Usa, Inc: H. D.Chief Regulatory And Quality Officer: S. K.Vice President & Head Of Business Development: F. A.. Explore Biosion's employee directory with LeadIQ.

What industry does Biosion belong to?

Minus sign iconPlus sign icon
Biosion operates in the Biotechnology Research industry.

What is Biosion's email format?

Minus sign iconPlus sign icon
Biosion's email format typically follows the pattern of first.last@biosion.com. Find more Biosion email formats with LeadIQ.

How much funding has Biosion raised to date?

Minus sign iconPlus sign icon
As of February 2024, Biosion has raised $1.5K in funding. The last funding round occurred on Apr 23, 2023.

When was Biosion founded?

Minus sign iconPlus sign icon
Biosion was founded in 2017.
Biosion

Biosion

Biotechnology ResearchJiangsu, China51-200 Employees

Biosion is a global R&D biotechnology company committed to developing antibody-based therapies to improve patient outcomes for the treatment of immune and oncologic diseases. Established in 2017, Biosion has built a pipeline of innovative biologics through its internally derived technologies including the H³ antibody discovery, SynTracer™ HT-endocytosis and Flexibody™ bispecific platforms. Biosion’s lead asset, BSI-045B (anti-TSLP mAb), is currently in phase 1 clinical trials for atopic dermatitis and severe asthma. Biosion and partners have plans to progress additional assets into the clinic for oncology indications over the next year. Biosion has operations in the US, Australia, and China. To learn more about Biosion visit www.biosion.com.

Section iconCompany Overview

Headquarters
Building D, 3-1 Zhongdan Unit, South Longshan Rd, Jiangbei New District 5th Floor Nanjing, Jiangsu 210061 CN
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $1.5K

    Biosion has raised a total of $1.5K of funding over 3 rounds. Their latest funding round was raised on Apr 23, 2023.

Section iconFunding & Financials

  • $1.5K

    Biosion has raised a total of $1.5K of funding over 3 rounds. Their latest funding round was raised on Apr 23, 2023.

© LeadIQ, Inc. All rights reserved.